FDA Inspection 1163285 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on February 9, 2022 in Orlando, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 9, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Orlando, FL (United States)